RUSSELL ERWIN: Open Payments
NPI 1700805801 · DENHAM SPRINGS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$544 in 16 payments from 10 companies in 2025. Trend: 2023 $153 · 2024 $159 · 2025 $544
Food & beverage: $544
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $214 |
| Axsome Therapeutics, Inc. | 3 | $160 |
| Antares Pharma, Inc. | 2 | $41 |
| ABBVIE INC. | 2 | $31 |
| Neurocrine BioSciences, Inc. | 1 | $29 |
| TOLMAR, INC. | 1 | $21 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
| Novo Nordisk Inc | 1 | $15 |
| Tris Pharma Inc | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $3 |
Products named: Auvelity, BREZTRI, AIRSUPRA, XYOSTED, QULIPTA, INGREZZA, JATENZO, CAPLYTA.
Industry payments across LA — which companies pay providers there.
